Fourth Quarter 2025 Overview (all comparisons are made to the corresponding prior year fourth quarter unless otherwise specified): Record net sales of $400.6 millionNet income of $12.0 million; Adjusted net income of $24.6 millionEBITDA of $34.3 million; Adjusted EBITDA of $44.7 millionDiluted EPS of $0.52; Adjusted EPS of $1.06Operating cash flow of $61.4 million; Free cash flow of $20.7 million for full year 2025Backlog of $514.1 million grew 22.5% CHATTANOOGA, Tenn., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Ast ...

Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite to serve patients in Southern US and add network capacity as RLT expands into earlier treatment lines and additional tumor typesCompany broke ground on 4 new manufacturing and R&D facilities, initiated 3 facility expansions, and announced 2 additional sites in last 10 months, rapidly making progress on its commitment to expand its US operations Basel, February 25, 2026 – Novartis, a l ...

HOUSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- U.S. Energy Corp. (NASDAQ: USEG) (“U.S. Energy” or the “Company”), an integrated energy company advancing a diversified industrial gas, energy, and carbon management platform, today released a new investor presentation highlighting its vertically integrated strategy, differentiated asset base, and operational milestones through 2027. The Company also announced its upcoming participation in the Emerging Growth Conference. "Our new investor presentation highlights wh ...

VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that on Sunday February 22nd, 2026, the community of Santa Ana authorized the Company to further advance mining exploration activities at the Pico Machay Gold Project (“Pico Machay” or the “Project”) in Peru. “This agreement underscores the strong, constructive relationship we are building together with the community of Santa Ana,” said Joanne Freeze, President and ...

Fourth quarter net revenue of $153 million, up 24% year-over-yearFourth quarter adjusted EBITDA of $13 millionFourth quarter net income of $6 million and fourth quarter adjusted net income of $12 millionFull year net revenue of $810 million, up 25% year-over-yearFull year adjusted EBITDA of $163 millionFull year net operating cash flow of $88 million and free cash flow of $84 million NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the four ...

DALLAS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Spring Valley Acquisition Corp. IV (the “Company”) announced today that, commencing on or about Monday, March 2, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units. The Class A ordinary shares and warrants that are separated are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the symbols “SVIV” and “SVIVW”, respectively. Any units not sep ...

VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sable Resources Ltd. ("Sable" or the "Company") (TSXV: SAE | OTCQB: SBLRF) is pleased to report the discovery of a new copper-mineralized zone, named Zorro North, located approximately 1.5 km northwest of the previously defined Zorro Cu target, at the Zorro Project in San Juan Province, Argentina (Figure 1). Sable’s previously released results from the Zorro Cu and Zorro Veins targets returned values up to 4.38% Cu, 140 g/t Au, and 584 g/t Ag (s ...

WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executive Officer of Upstream Bio, will be participating in the following upcoming investor conferences in March: TD Cowen 46th Annual Health Care Conference, Boston, MAWednesday, March 4, 2026, Fireside Chat - 9:50 a.m. ET2026 Leerink Partners Global ...

MONTVALE, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corp ...

WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced that the Company will participate in a hybrid presentation followed by an analyst-led Q&A session at the TD Cowen 46th Annual Health Care Conference being held at the Boston Marriott Copley Place in Boston, MA on Wednesday, March 4, 20 ...